• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts HealthDay News

Category Archive

  • HealthDay News / October 1, 2020

    September 2020 Briefing – Pediatrics

    View Post
  • HealthDay News / October 21, 2020

    Interval Breast Cancers Tied to Worse Outcomes

    View Post
  • HealthDay News / August 13, 2019

    Racial, Ethnic Disparities in Care for Preemies Have Narrowed

    View Post
  • HealthDay News / October 19, 2020

    COVID-19-Linked Deaths Mainly in Seniors in May to August 2020

    View Post
  • HealthDay News / October 21, 2020

    Fauci ‘Cautiously Optimistic’ for COVID-19 Vaccine by Year’s End

    View Post
View Post

Specific Factors Tied to Unemployment With MS Diagnosis

In HealthDay News
by Healthday
October 9, 2020

Many of the factors related to maintenance of employment are alterable

View Post

Disparities in Insulin Pump Use Persist, 2005 to 2019

In HealthDay News
by Healthday
October 9, 2020

Use higher among White children with type 1 diabetes versus Black and Hispanic children

View Post

Timing of Puberty Linked to Risk for Self-Harm in Adolescence

In HealthDay News
by Healthday
October 9, 2020

Earlier puberty associated with higher risk for self-harm at 16 years of age

View Post

Bedside Tracheotomy Feasible for Critically Ill COVID-19 Patients

In HealthDay News
by Healthday
October 9, 2020

No infection identified among surgeons following procedure; postoperative complications rarely seen

View Post

T2DM Links to Risk for Dementia Differ by Type, Glycemic Control

In HealthDay News
by Healthday
October 9, 2020

Dose-response association shows higher risk for dementia with HbA1c >87 versus <52 mmol/mol

View Post

CDC: U.S. COVID-19 Deaths Could Reach 233,000 by End of October

In HealthDay News
by Healthday
October 9, 2020

And, dual coronavirus-flu vaccine to start human trials

View Post

Remdesivir Cuts Time to COVID-19 Recovery

In HealthDay News
by Healthday
October 9, 2020

However, no significant difference in mortality found between remdesivir and placebo groups

View Post

COVID-19 Symptoms Often Prolonged in Pregnant Women

In HealthDay News
by Healthday
October 8, 2020

Most prevalent first symptoms cough, sore throat, body aches, fever for those testing positive for SARS-CoV-2

View Post

Lifetime Prevalence of Suicide Ideation 17.4 Percent Among Doctors

In HealthDay News
by Healthday
October 8, 2020

Lifetime prevalence of suicide attempts 1.8 percent, with one-year prevalence of 0.3 percent

View Post

Measurable Residual Disease Negativity Tied to Survival in AML

In HealthDay News
by Healthday
October 8, 2020

AML patients without MRD have higher estimated rates of five-year disease-free, overall survival

  • Page 121 of 149
  • ←
  • 1
  • ...
  • 120
  • 121
  • 122
  • ...
  • 149
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer